Metraipolis › archive › dc_7de07984ba8d
Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma — Europe PMC PMID:42528212
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42528212
- DOI
- 10.5761/atcs.oa.26-00107
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T06:40:34.944Z
- SHA-256 of the archived text
4b085e2f12fbf00bb25f6de2a295284ec5fb3dda17ba8d062352584a68f813a2- Stable URL of this page
https://metraipolis.com/documento/dc_7de07984ba8d
How to cite
Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma — Europe PMC PMID:42528212 — Europe PMC (en), https://europepmc.org/article/MED/42528212 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7de07984ba8d (Metraipolis archive dc_7de07984ba8d, sha256 4b085e2f12fbf00bb25f6de2a295284ec5fb3dda17ba8d062352584a68f813a2)
BibTeX
@misc{dc7de07984ba8d,
title = {Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma — Europe PMC PMID:42528212},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42528212},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7de07984ba8d; sha256 4b085e2f12fbf00bb25f6de2a295284ec5fb3dda17ba8d062352584a68f813a2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42528212. Agents can read the archived copy with the MCP tool read_document.